Cargando…

Dupilumab maintenance therapy in an asthmatic patient with coronavirus disease 2019 pneumonia

Detalles Bibliográficos
Autores principales: Tanabe, Naoya, Matsumoto, Hisako, Hamada, Satoshi, Ito, Isao, Hirai, Toyohiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society of Allergology. Production and hosting by Elsevier B.V. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648507/
https://www.ncbi.nlm.nih.gov/pubmed/33208274
http://dx.doi.org/10.1016/j.alit.2020.10.005
_version_ 1783607125946138624
author Tanabe, Naoya
Matsumoto, Hisako
Hamada, Satoshi
Ito, Isao
Hirai, Toyohiro
author_facet Tanabe, Naoya
Matsumoto, Hisako
Hamada, Satoshi
Ito, Isao
Hirai, Toyohiro
author_sort Tanabe, Naoya
collection PubMed
description
format Online
Article
Text
id pubmed-7648507
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Japanese Society of Allergology. Production and hosting by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-76485072020-11-09 Dupilumab maintenance therapy in an asthmatic patient with coronavirus disease 2019 pneumonia Tanabe, Naoya Matsumoto, Hisako Hamada, Satoshi Ito, Isao Hirai, Toyohiro Allergol Int Letter to the Editor Japanese Society of Allergology. Production and hosting by Elsevier B.V. 2021-04 2020-11-07 /pmc/articles/PMC7648507/ /pubmed/33208274 http://dx.doi.org/10.1016/j.alit.2020.10.005 Text en © 2020 Japanese Society of Allergology. Production and hosting by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Tanabe, Naoya
Matsumoto, Hisako
Hamada, Satoshi
Ito, Isao
Hirai, Toyohiro
Dupilumab maintenance therapy in an asthmatic patient with coronavirus disease 2019 pneumonia
title Dupilumab maintenance therapy in an asthmatic patient with coronavirus disease 2019 pneumonia
title_full Dupilumab maintenance therapy in an asthmatic patient with coronavirus disease 2019 pneumonia
title_fullStr Dupilumab maintenance therapy in an asthmatic patient with coronavirus disease 2019 pneumonia
title_full_unstemmed Dupilumab maintenance therapy in an asthmatic patient with coronavirus disease 2019 pneumonia
title_short Dupilumab maintenance therapy in an asthmatic patient with coronavirus disease 2019 pneumonia
title_sort dupilumab maintenance therapy in an asthmatic patient with coronavirus disease 2019 pneumonia
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648507/
https://www.ncbi.nlm.nih.gov/pubmed/33208274
http://dx.doi.org/10.1016/j.alit.2020.10.005
work_keys_str_mv AT tanabenaoya dupilumabmaintenancetherapyinanasthmaticpatientwithcoronavirusdisease2019pneumonia
AT matsumotohisako dupilumabmaintenancetherapyinanasthmaticpatientwithcoronavirusdisease2019pneumonia
AT hamadasatoshi dupilumabmaintenancetherapyinanasthmaticpatientwithcoronavirusdisease2019pneumonia
AT itoisao dupilumabmaintenancetherapyinanasthmaticpatientwithcoronavirusdisease2019pneumonia
AT hiraitoyohiro dupilumabmaintenancetherapyinanasthmaticpatientwithcoronavirusdisease2019pneumonia